NEW YORK (GenomeWeb News) – Celera Corporation and Abbott announced today that they have revised their strategic alliance agreement, moving from a profit-sharing deal to new worldwide distribution and royalty agreements.

Under one of these agreements, Abbott will have the right to exclusively distribute certain Celera-manufactured molecular diagnostic products. A second agreement gives Celera royalties on sales of m2000 real-time PCR system reagents, instruments, services, and related consumables.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.